نتایج جستجو برای: stereotaxy

تعداد نتایج: 155  

Journal: :Movement disorders : official journal of the Movement Disorder Society 2009
Constantine Constantoyannis George C Kagadis John Ellul Zinovia Kefalopoulou Elisabeth Chroni

Deep brain stimulation (DBS) of the thalamus, zona incerta, subthalamic nucleus, and pallidum has been used for the treatment of dystonia. Reports on thalamic DBS for dystonia were published as early as 1977. Thalamic stimulation may increase the dystonic symptoms, especially when the Vim nucleus is the target of the stimulation. However, targeting the thalamus was abandoned because several pub...

Journal: :Stroke 2005
Joseph P Broderick

Until the present, intracerebral hemorrhage (ICH) has been the stroke subtype that has defied attempts to find a scientifically proven effective therapy. Possible treatments of acute ICH include: (1) slowing or stopping of the bleeding during the first several hours after onset or (2) removal of the accumulated hematoma to prevent the mechanical complications of mass effect as well as the toxic...

2008
M. Cercignani G. Koch C. Caltagirone M. Bozzali

Introduction Transcranial magnetic stimulation (TMS) not only changes neural activity at the site of stimulation, but also affects interconnected cortical and subcortical areas [1]. Recently, a new method which uses a twin-coil or ‘paired-pulse’ TMS paradigm has been proposed for studying functional ‘connections’ between posterior parietal cortex (PPC) and ipsilateral motor cortex (M1) non-inva...

2010
Robert A. Fishman Diane M. Jaworski Holly M. Stradecki Paul L. Penar Caroline J. Pennington Dylan R. Edwards

ANGIOGENESIS AND INVASION AI-01. CASE REPORT: OPTIC NEUROPATHY IN A PATIENT WITH GLIOBLASTOMA RECEIVING BEVACIZUMAB Robert A. Fishman , Erik Happ , Tracey Stevens , and Lara Kunschner ; Allegheny General Hospital Bevacizumab, a humanized monoclonal antibody developed to target and subsequently block vascular endothelial growth factor, received FDA approval for single agent treatment of recurren...

2002
Nancy D. Doolittle Lauren E. Abrey Nicolay Ferrari Walter A. Hall Edward R. Laws Roger E. McLendon Leslie L. Muldoon David Peereboom Darryl R. Peterson C. Patrick Reynolds Peter Senter Edward A. Neuwelt

The November 2000 NIH report of the Brain Tumor Progress Review Group identified delivering and targeting therapeutic agents as a priority in the treatment of malignant brain tumors. For this reason, the seventh annual Blood-Brain Barrier Disruption Consortium meeting, partially funded by an NIH R13 Grant, focused on recent advances in targeted delivery to the central nervous system, clinical t...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید